Search results

TriMas (TRS) came out with quarterly earnings of $0.52 per share, beating the Zacks Consensus Estimate of $0.49 per share. This compares to earnings of $0.61 per share a year ago. These figures are

Definium Therapeutics, Inc. (DFTX) closed the last trading session at $44.49, gaining 0.7% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets

When it comes to short-term investing or trading, they say "the trend is your friend." And there's no denying that this is the most profitable strategy. But making sure of the sustainability of a

When it comes to short-term investing or trading, they say "the trend is your friend." And there's no denying that this is the most profitable strategy. But making sure of the sustainability of a

Shares of KBR Inc. (KBR) have gained 3.6% over the past four weeks to close the last trading session at $35.93, but there could still be a solid upside left in the stock if short-term price targets

Shares of EuroDry (EDRY) have gained 15.5% over the past four weeks to close the last trading session at $25.51, but there could still be a solid upside left in the stock if short-term price targets

The market expects Tetra Technologies (TTI) to deliver flat earnings compared to the year-ago quarter on higher revenues when it reports results for the quarter ended June 2026. This widely-known

When it comes to short-term investing or trading, they say "the trend is your friend." And there's no denying that this is the most profitable strategy. But making sure of the sustainability of a

While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies. With

In the latest close session, Take-Two Interactive (TTWO) was up +1.5% at $247.62. The stock's change was more than the S&P 500's daily gain of 0.21%. Elsewhere, the Dow saw an upswing of 1.03%

Nektar Therapeutics (NKTR) closed the last trading session at $71.35, gaining 9.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by

Shares of Belden (BDC) have gained 1.5% over the past four weeks to close the last trading session at $117.11, but there could still be a solid upside left in the stock if short-term price targets

Shares of Nabors Industries (NBR) have gained 0.9% over the past four weeks to close the last trading session at $83.37, but there could still be a solid upside left in the stock if short-term price

Visteon (VC) closed the last trading session at $103.75, gaining 0.7% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street

NovoCure (NVCR) closed the last trading session at $17.65, gaining 14.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.

The popular research

Two factors often determine stock prices in the long run: earnings and interest rates. Investors can't control the latter, but they can focus on a company's earnings results every quarter.

The

Shares of AppFolio (APPF) have gained 11.2% over the past four weeks to close the last trading session at $178.27, but there could still be a solid upside left in the stock if short-term price